CN Patent

CN101068793A — Hiv整合酶抑制剂的钾盐

Assigned to Msd Uk Ltd · Expires 2007-11-07 · 19y expired

What this patent protects

公开了化合物A的钾盐和制备它们的方法，其中化合物A具有下面通式：(化合物A)。化合物A是HIV整合酶抑制剂，可用于治疗或预防HIV感染，延迟艾滋病的发病，以及治疗或预防艾滋病。

USPTO Abstract

公开了化合物A的钾盐和制备它们的方法，其中化合物A具有下面通式：(化合物A)。化合物A是HIV整合酶抑制剂，可用于治疗或预防HIV感染，延迟艾滋病的发病，以及治疗或预防艾滋病。

Drugs covered by this patent

raltegravir-potassium (RALTEGRAVIR POTASSIUM)

Patent Metadata

Patent number: CN101068793A
Jurisdiction: CN
Classification: —
Expires: 2007-11-07
Drug substance claim: No
Drug product claim: No
Assignee: Msd Uk Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.